Suivre
Jialu Li (李嘉路), PhD
Jialu Li (李嘉路), PhD
Statistician at Novartis; Founded HuaJiaBio; Previously at GHI, MD Anderson & CAS
Adresse e-mail validée de novartis.com
Titre
Citée par
Citée par
Année
Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor
XY Ge*, JL Li*, XL Yang, AA Chmura, G Zhu, JH Epstein, JK Mazet, B Hu, ...
Nature 503 (7477), 535-538, 2013
22432013
Serological evidence of ebolavirus infection in bats, China
J Yuan, Y Zhang, J Li, Y Zhang, LF Wang, Z Shi
Virology journal 9, 1-5, 2012
1562012
ADORA1 inhibition promotes tumor immune evasion by regulating the ATF3-PD-L1 axis
H Liu, X Kuang, Y Zhang, Y Ye, J Li, L Liang, Z Xie, L Weng, J Guo, H Li, ...
Cancer cell 37 (3), 324-339. e8, 2020
1522020
Genetic diversity of novel circular ssDNA viruses in bats in China
X Ge, J Li, C Peng, L Wu, X Yang, Y Wu, Y Zhang, Z Shi
Journal of General Virology 92 (11), 2646-2653, 2011
1432011
Accurate RNA sequencing from formalin-fixed cancer tissue to represent high-quality transcriptome from frozen tissue
J Li, C Fu, TP Speed, W Wang, WF Symmans
JCO precision oncology 2, 1-9, 2018
522018
The Beneficial Role of Sunitinib in Tumor Immune Surveillance by Regulating Tumor PD‐L1
H Li, X Kuang, L Liang, Y Ye, YC Zhang, J Li, F Ma, J Tao, G Lei, S Zhao, ...
Advanced Science, 2020
502020
Detection of diverse novel astroviruses from small mammals in China
B Hu, AA Chmura, J Li, G Zhu, JS Desmond, Y Zhang, W Zhang, ...
Journal of general virology 95 (11), 2442-2449, 2014
452014
Risk assessment of progression to severe conditions for patients with COVID-19 pneumonia: a single-center retrospective study
L Zeng, J Li, M Liao, R Hua, P Huang, M Zhang, Y Zhang, Q Shi, Z Xia, ...
MedRxiv, 2020.03. 25.20043166, 2020
282020
Bayesian estimation of a semiparametric recurrent event model with applications to the penetrance estimation of multiple primary cancers in Li-Fraumeni syndrome
J Li, SJ Shin, J Ning, J Bojadzieva, LC Strong, W Wang
arXiv preprint arXiv:1804.06883, 2018
22*2018
Bat adeno-associated viruses as gene therapy vectors with the potential to evade human neutralizing antibodies
Y Li, J Li, Y Liu, Z Shi, H Liu, Y Wei, L Yang
Gene Therapy 26 (6), 264-276, 2019
212019
Estimating TP53 Mutation Carrier Probability in Families with Li–Fraumeni Syndrome Using LFSPRO
G Peng, J Bojadzieva, ML Ballinger, J Li, AL Blackford, PL Mai, ...
Cancer Epidemiology, Biomarkers & Prevention 26 (6), 837-844, 2017
192017
Combining texture features of whole slide images improves prognostic prediction of recurrence-free survival for cutaneous melanoma patients
Y Peng, Y Chu, Z Chen, W Zhou, S Wan, Y Xiao, Y Zhang, J Li
World Journal of Surgical Oncology, 2020
162020
Development of a Novel Prognostic Score Combining Clinicopathologic Variables, Gene Expression and Mutationprofiles for Lung Adenocarcinoma
G Li, G Wang, Y Guo, S Li, Y Zhang, J Li, B Peng
World Journal of Surgical Oncology, 2020
42020
Severity-onset prediction of COVID-19 via artificial-intelligence analysis of multivariate factors
Y Fu, L Zeng, P Huang, M Liao, J Li, M Zhang, Q Shi, Z Xia, X Ning, J Mo, ...
Heliyon 9 (8), 2023
22023
Recurrence risk stratification of hepatocellular carcinomas based on immune gene expression and features extracted from pathological images
T Ding, X Li, J Mo, G Alexander, J Li
PLOS Computational Biology 19 (12), e1011716, 2023
2023
Development of a novel prognostic model based on clinicopathological and expressional profiles for cutaneous melanoma patients
Y Peng, Y Chu, Z Chen, W Zhou, S Wan, Y Xiao, Y Zhang, J Li
Int J Clin Exp Med, 5717-5725, 2020
2020
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–16